Published in Health Business Week, May 1st, 2009
The grant is from Susan G. Komen for the Cure® and the Triple Negative Breast Cancer Foundation.
The $6.4 million will be used to evaluate experimental drugs in combination with standard therapies to treat triple-negative tumors, which are more common in young African-American and Hispanic women. UAB scientists also plan to explore ways to better predict which...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Health Business Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.